Olr1245 Activators
Chemical activators of Olr1245 can initiate their action through a variety of intracellular signaling pathways that converge on the activation of this protein. Forskolin, for instance, directly stimulates adenylate cyclase, leading to an increase in cyclic AMP (cAMP) within the cell. The elevated cAMP levels can activate protein kinase A (PKA), a kinase known to phosphorylate numerous substrates, including Olr1245. Similarly, Isoproterenol, a beta-adrenergic receptor agonist, also raises intracellular cAMP levels, fostering a conducive environment for PKA activation, which in turn can phosphorylate and activate Olr1245. Another compound, 3-Isobutyl-1-methylxanthine (IBMX), prevents the breakdown of cAMP by inhibiting phosphodiesterases, thereby maintaining enhanced PKA activity which can lead to Olr1245 phosphorylation and activation.
Calcium signaling is another pathway through which Olr1245 can be activated. Compounds such as Ionomycin and Thapsigargin elevate intracellular calcium levels, which activate calmodulin-dependent kinase (CaMK). Activated CaMK can phosphorylate targets including Olr1245, leading to its activation. The calcium ionophore A23187 (Calcimycin) also raises cytosolic calcium levels, potentially initiating a cascade of kinase activation resulting in the phosphorylation of Olr1245. FPL 64176 and BAY K8644 both enhance L-type calcium channel activity, which can increase intracellular calcium and indirectly activate Olr1245 via calcium-dependent kinases. Additionally, Phorbol 12-myristate 13-acetate (PMA) serves as an activator of protein kinase C (PKC), which can phosphorylate Olr1245, leading to activation. Anandamide activates cannabinoid receptors that trigger downstream signaling cascades involving kinases that can phosphorylate and activate Olr1245. Zinc sulfate is essential for the function of various enzymes and kinases, which includes those that can phosphorylate Olr1245. Lastly, Dibutyryl cAMP, a cAMP analog, directly activates PKA, fostering the phosphorylation and subsequent activation of Olr1245.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Acts as an agonist for beta-adrenergic receptors, increasing cAMP levels and subsequently activating PKA, which may phosphorylate Olr1245. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, preventing cAMP degradation, thus sustaining PKA activation which may lead to Olr1245 activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium, which can activate CaMK. CaMK may then phosphorylate and activate Olr1245. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits SERCA, elevating cytosolic calcium levels and potentially activating kinases like CaMK, which could activate Olr1245. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Acts as a calcium ionophore, raising cytosolic calcium levels which may lead to the activation of kinases capable of phosphorylating Olr1245. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
Selectively increases L-type calcium channel activity, potentially elevating calcium-dependent kinase activity that could activate Olr1245. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Enhances L-type calcium channel activity, potentially leading to activation of calcium-dependent kinases that may activate Olr1245. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which may phosphorylate and activate Olr1245. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Essential for the function of various kinases, which may include those that phosphorylate and activate Olr1245. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A stable cAMP analog that directly activates PKA, which could then phosphorylate and lead to the activation of Olr1245. | ||||||